R

Rajambal

Active Director Director DIN 08124523
DIN 08124523 First appointment May 2018 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since May 2018
Shareholding value Locked Premium profile

About Rajambal

Rajambal has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Einstek Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08124523
Primary Designation Director
First Appointment 02 May 2018
Oldest Company Age 10 yrs

Current companies

Company Designation Appointment Founded Status
Einstek Pharma Private Limited U24230KA2016PTC085446
Director 02 May 2018 2016 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Einstek Pharma Private Limited
Premium access

Shareholding and investment profile for Rajambal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajambal

Rajambal has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Einstek Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Rajambal is associated with 1 company as Director.

Rajambal has expertise in General Business.

Rajambal has 8 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available